Development, Optimization, and Pharmacokinetics Study of Bufalin/Nintedanib Co-loaded Modified Albumin Sub-microparticles Fabricated by Coaxial Electrostatic Spray Technology
Crossref DOI link: https://doi.org/10.1208/s12249-021-02163-y
Published Online: 2021-12-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Peng
Lu, Shengzhe
Pan, Bin
Xu, Ying
Text and Data Mining valid from 2021-12-09
Version of Record valid from 2021-12-09
Article History
Received: 27 May 2021
Accepted: 14 October 2021
First Online: 9 December 2021
Declarations
:
: The authors declare no competing interests.